Global Point-of-Care Diagnostics Market Poised for Growth Amid Rising Chronic and Infectious Diseases

The POC Diagnostics Market is expected to grow from an estimated USD 51.26 billion in 2024 to USD 118.91 billion in 2033, at a CAGR of 9.8%. The global point-of-care (POC) diagnostics market is witnessing significant growth, driven by the increasing prevalence of chronic and infectious diseases. With conditions such as diabetes, cardiovascular diseases, and respiratory disorders on the rise, the demand for rapid and accessible diagnostic solutions has never been higher.

POC diagnostic devices, such as glucose monitors and cholesterol testing kits, are revolutionizing healthcare by enabling patients to manage their health more effectively. These technologies reduce hospital visits and provide immediate results, which is crucial for disease management. In November 2022, LumiraDx Healthcare launched its high-sensitivity CRP POC antigen test in India, aimed at reducing unnecessary antibiotic prescriptions and combating antimicrobial resistance.

Download Free Exclusive Sample PDF@ https://www.emergenresearch.com/request-sample/3561

The COVID-19 pandemic further highlighted the importance of POC diagnostics. Rapid antigen and molecular testing kits played a critical role in managing the spread of the virus, particularly in remote and resource-limited areas. The efficiency and convenience of these tests underscored their value in public health crises and routine healthcare.

The POC Diagnostics Market report also offers details about market size, market share, revenue growth, and CAGR during the forecast period. The report also offers key insights about top companies in the market along with a thorough SWOT analysis, Porter’s Five Forces analysis, and feasibility analysis to offer competitive edge to the readers. The report focuses on the recent trends, major challenges and opportunities, and limitations pertaining to the ongoing pandemic.

Technological Innovations Driving Market Expansion

Advancements in microfluidics, biosensors, and nanotechnology are enhancing the accuracy and efficiency of POC diagnostics. Microfluidics enables the miniaturization of devices, making them more portable and user-friendly. Biosensors are improving detection capabilities, with optical biosensors being increasingly used for identifying infectious agents. Wearable biosensor technology is also gaining traction, allowing continuous health monitoring in real time.

In June 2022, U.S.-based startup StataDx acquired licensing rights for the eRapid electrochemical biosensor technology from Harvard University’s Wyss Institute. This technology has the potential to revolutionize diagnostic testing by providing faster and more precise results.

Nanotechnology is playing a crucial role in improving diagnostic sensitivity. The use of gold nanoparticles and quantum dots enhances signal amplification in diagnostic assays, ensuring higher accuracy in POC testing. This innovation has paved the way for the development of highly portable and efficient diagnostic tools without compromising performance.

Challenges Hindering Market Growth

Despite the advantages of POC diagnostics, high costs remain a major challenge, particularly in low- and middle-income countries. Advanced POC systems incorporate sophisticated technologies such as artificial intelligence, biosensors, and microfluidics, leading to increased production costs. As a result, healthcare facilities in resource-constrained regions struggle to afford these devices, limiting their accessibility.

Molecular POC platforms, which are widely used for detecting infectious diseases, often require significant financial investment, making them out of reach for many smaller healthcare centers. Addressing cost barriers through government support and technological advancements will be essential in ensuring wider adoption of POC diagnostics worldwide.

Acquire the complete research report on the Global Market@ https://www.emergenresearch.com/industry-report/poc-diagnostics-market

Market Segmentation and Growth Opportunities

The demand for POC glucose monitoring devices is particularly high among diabetes patients. These devices provide real-time blood glucose level measurements, helping users make informed decisions regarding diet, exercise, and medication. Traditional laboratory-based glucose testing methods take longer to process results, whereas POC devices offer immediate insights, enabling timely interventions.

A significant milestone in POC glucose monitoring was achieved in June 2023 when South Korea’s Ministry of Food and Drug Safety approved the country’s first domestically produced continuous glucose monitoring (CGM) device. Developed by I-SENS, the CareSens Air is the smallest and lightest CGM system in South Korea, designed for continuous operation for up to 15 days with an advanced calibration mechanism.

The home care and self-testing segment is expected to witness the fastest growth in the POC diagnostics market. The rising popularity of at-home diagnostic tools, such as glucometers and portable ECG monitors, has empowered individuals to monitor their health conditions more effectively. These devices not only reduce dependency on frequent clinical visits but also lower healthcare costs and improve treatment adherence.

Self-testing is also becoming increasingly important for preventive care and early detection. Products such as pregnancy tests, ovulation kits, and rapid COVID-19 antigen tests provide users with quick and reliable results from the comfort of their homes. Many of these devices now integrate with digital platforms, allowing seamless data sharing with healthcare providers for remote diagnosis and treatment adjustments. In March 2023, Cue Health launched a suite of diagnostic test kits that enable users to perform precise and reliable tests at home, enhancing convenience and accessibility.

POC Diagnostics Top Companies and Competitive Landscape

The Plasma Medicine market involves the use of cold plasma technology for applications in wound healing, cancer treatment, and dental care, among others. The market is witnessing rapid advancement and is gaining increased adoption. Companies such as Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers, with a strong foothold in diagnostics and healthcare solutions, are likely to extend their expertise into plasma-based diagnostic and therapeutic solutions.

With established research and development capabilities and global reach, they are better positioned to drive the integration of plasma medicine into mainstream healthcare practices. The Key players operating in the POC Diagnostics Market includes Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, BD (Becton, Dickinson and Company), Thermo Fisher Scientific, Medtronic, Quidel Corporation, Cepheid, Horiba Medical, OraSure Technologies, and Others.

QuantuMDx Group Limited is a U.K.-based point-of-care diagnostics company that, in May 2022, launched a new respiratory panel test for the detection of COVID-19, Flu A, Flu B, and RSV.

Some of the key companies in the global POC Diagnostics market include:

Abbott Laboratories

Roche Diagnostics

Siemens Healthineers

BD (Becton, Dickinson and Company)

Thermo Fisher Scientific

Medtronic

Quidel Corporation

Cepheid

Horiba Medical

OraSure Technologies

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/3561

POC Diagnostics Latest Industry Updates

In October 2022, Genes2Me Pvt. Ltd introduced the Rapi-Q Point-of-Care RT-PCR solution for the speedy and precise detection of HPV and tuberculosis. This CE-IVD-certified system is pretty easy to operate and will provide results in less than 45 minutes with extremely high sensitivity, reliable detection, and excellent performance.

POC Diagnostics Market Segmentation Analysis

By Product Outlook (Revenue, USD Billion; 2020-2033)

COVID-19 test products

Glucose Monitoring Products

Strips

Meters

Lancets & Lancing Devices

Cardiometabolic Monitoring Products

Point-of-care and rapid diagnostics Products

Blood Gas/Electrolyte Testing Products

HbA1c Testing Products

Infectious Disease Testing Products

Influenza Testing Products

HIV Testing Products

Hepatitis C Testing Products

Influenza Testing Products

Sexually Transmitted Disease Testing Products

Syphilis Testing Products

Human Papillomavirus (HPV) Testing Products

Chlamydia Trachomatis Testing Products

Herpes simplex virus (HSV) Testing Products

Healthcare-associated Infection Testing Products

Respiratory Infection Testing Products

Tuberculosis (TB) Testing Products

Clostridium Difficile Infection (CDI) Testing Products

Tropical Disease Testing Products

Other Infectious Disease Testing Products

Coagulation Monitoring Products

PT/INR Testing

ACT/APTT

Pregnancy & Fertility Testing Products

Pregnancy Testing Products

Fertility Testing Products

Tumor/Cancer Marker Testing Products

Urinalysis Testing Products

Cholesterol Testing Products

Hematology Testing Products

Thyroid Stimulating Hormone (TSH) Testing Products

Drugs-of-abuse Testing Products

Fecal Occult Testing Products

Other POC Products

By Platform Outlook (Revenue, USD Billion; 2020-2033)

Lateral Flow Assays

Dipsticks

Microfluidics

Molecular Diagnostics

Polymerase Chain Reaction (PCR)

Isothermal Nucleic Acid Amplification Technology (INAAT)

Other Molecular Diagnostic Technologies

Immunoassays

By Mode of Purchase Outlook (Revenue, USD Billion; 2020-2033)

Prescription-based Products

OTC Products

By Sample Outlook (Revenue, USD Billion; 2020-2033)

Blood Sample

Urine Sample

Nasal and Oropharyngeal Swabs Sample

Other Samples

By End-Use Outlook (Revenue, USD Billion; 2020-2033)

Clinical Laboratories

Ambulatory Care Facilities and Physician Offices

Pharmacies, retail clinics, & E-comm. Platforms

Hospitals, Critical Care Centers, Urgent care centers

Home Care & Self Testing

Other End Users

By Regional Outlook (Revenue, USD Billion; 2020-2033)

North America

United States

Canada

Mexico

Europe

Germany

France

United Kingdom

Italy

Spain

Benelux

Rest of Europe

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Latin America

Brazil

Rest of Latin America

Middle East and Africa

Saudi Arabia

UAE

South Africa

Turkey

Rest of MEA

Request For Customization Report@ https://www.emergenresearch.com/request-for-customization/3561

Key insights presented in the report:

Market revenue shares by major business players, by type, by application, and market scope of global POC Diagnostics market

Sales revenue by key players and new entrants

Competitive analysis of the key players including aspects such as company overview, product or services specification, vendors, and buyers.

Recent mergers, acquisitions, product launches, recent investments, and joint ventures

Regional analysis to provide insight to recent trends and opportunities

The report also covers the scope of individual applications and types in each region. The report also covers details about production and consumption patterns, technological developments, revenue growth, market size, market share, key trends and demands influencing market growth in the region, and robust presence of key players in the region.

Thank you for reading our report. For further details or to inquire about customization, please let us know and we will offer you the report as per your needs.